myeloid differentiation
Treatment with HSYA also alleviated increased expressions of tumor necrosis factor (TNF)-a, interleukin (IL)-1b, IL-6, transforming growth factor (TGF)-b1, collagen (Col) I, Col III, a-smooth muscle actin (a-SMA), myeloid differentiation (MD)-2, Toll-like receptor 4 (TLR4) and cluster differentiation (CD)14 at the mRNA (RT-PCR) and protein levels (Western blot and enzyme-linked immuno sorbent assay).